Assembly Biosciences to present herpes drug data at ESCMID conference

April 9, 2026 8:02 AM

Assembly Biosciences Inc. (NASDAQ: ASMB) announced that Phase 1b clinical data for two herpes simplex virus drug candidates will be ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found